| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/21/2011 | US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 07/21/2011 | US20110177073 Recombinant production of mixtures of antibodies |
| 07/21/2011 | US20110177070 TGF-Beta Antagonist Multi-Target Binding Proteins |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177054 Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
| 07/21/2011 | US20110177053 Non-cytotoxic protein conjugates |
| 07/21/2011 | US20110177043 Method of improving differentiation of chondrogenic progenitor cells |
| 07/21/2011 | US20110177038 Inhibition of Tumor Growth via Peroxiredoxin 3 |
| 07/21/2011 | US20110177029 O-linked glycosylation using n-acetylglucosaminyl transferases |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110177003 Proteins that fluoresce at infrared wavelengths or generate singlet oxygen upon illumination |
| 07/21/2011 | US20110174623 Concentration and Purification of Analytes Using Electric Fields |
| 07/21/2011 | US20110174322 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 07/21/2011 | DE102010018109A1 New sulfate transferase comprising specified amino acid sequence or its partial sequence or conservative variations, useful to produce sulfated compounds including liponucleoside derivatives, nucleoside derivatives and aromatic compounds |
| 07/21/2011 | DE102010004541A1 Chimäre humane beta-Defensine Chimeric human beta-defensins |
| 07/21/2011 | CA2787253A1 Production of hydrocarbons in microorganisms |
| 07/21/2011 | CA2787027A1 Detection of gastrointestinal disorders |
| 07/21/2011 | CA2787016A1 Therapeutic apyrase constructs, apyrase agents, and production methods |
| 07/21/2011 | CA2786847A1 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs) |
| 07/21/2011 | CA2786813A1 Compositions and methods for minimizing nornicotine synthesis in tobacco |
| 07/21/2011 | CA2786697A1 Plant regulatory elements and uses thereof |
| 07/21/2011 | CA2786696A1 Oligonucleotides and methods for detecting kras and pik3ca mutations |
| 07/21/2011 | CA2786660A1 Liver targeting molecules |
| 07/21/2011 | CA2786336A1 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity |
| 07/21/2011 | CA2786335A1 Bacterial host strain comprising a mutant spr gene and having reduced tsp activity |
| 07/21/2011 | CA2786244A1 Constructs, vectors and cyanobacteria for the synthesis of fatty alcohols, and methods for producing fatty alcohols in cyanobacteria |
| 07/21/2011 | CA2786201A1 Novel mannanase variants |
| 07/21/2011 | CA2785931A1 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene |
| 07/21/2011 | CA2785212A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/21/2011 | CA2785020A1 Processes and kits for identifying aneuploidy |
| 07/21/2011 | CA2781730A1 Branched-chain fatty acids and biological production thereof |
| 07/20/2011 | EP2345746A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 07/20/2011 | EP2345742A1 RNA sequence-specific mediators of RNA interference |
| 07/20/2011 | EP2345741A1 METHOD FOR MEASURING SURVIVIN mRNA |
| 07/20/2011 | EP2345739A2 A microfluidic device for processing polynucleotide-containing samples |
| 07/20/2011 | EP2345734A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media |
| 07/20/2011 | EP2345732A1 Methods for intracellular delivery of nucleic acids |
| 07/20/2011 | EP2345731A1 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 07/20/2011 | EP2345730A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use |
| 07/20/2011 | EP2345729A2 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar |
| 07/20/2011 | EP2345728A1 Yeast membrane protein expression system and its application in drug screening |
| 07/20/2011 | EP2345727A2 Fungal promoter for expressing a gene in a fungal cell |
| 07/20/2011 | EP2345726A2 Fungal promoter for expressing a gene in a fungal cell |
| 07/20/2011 | EP2345725A1 Use of gene in the synthesis of astaxanthin |
| 07/20/2011 | EP2345724A1 G-CSF analog compositions and methods |
| 07/20/2011 | EP2345723A1 Method for isolation of soluble polypeptides |
| 07/20/2011 | EP2345722A1 Mutations in the parkin gene, compositions, methods and uses |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345719A1 Method for isolating small RNA |
| 07/20/2011 | EP2345718A2 Compositions and methods for siRNA inhibition of angiogenesis |
| 07/20/2011 | EP2345717A1 Cinerarium-derived chromosomal dna involved in synthesis of flavonoid, and use thereof |
| 07/20/2011 | EP2345716A1 Recombinant influenza viruses for vaccines and gene therapy |
| 07/20/2011 | EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof |
| 07/20/2011 | EP2345672A1 Anti-glycated cd59 antibodies and uses thereof |
| 07/20/2011 | EP2345669A1 NPC1L1 (NPC3) and methods of use thereof |
| 07/20/2011 | EP2345665A2 Flavivirus NS1 subunit vaccine |
| 07/20/2011 | EP2345664A2 Replikin peptides and uses thereof |
| 07/20/2011 | EP2345662A1 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 07/20/2011 | EP2345428A2 Preparation method of prostate tumor-targeted double-regulated oncolytic adenovirus expressing superantigen gene |
| 07/20/2011 | EP2345424A1 CD4-specific antibody TRX1 and uses therefor |
| 07/20/2011 | EP2344891A2 Msp nanopores and related methods |
| 07/20/2011 | EP2344686A1 Novel triple tag sequences and methods of use thereof |
| 07/20/2011 | EP2344678A2 Methods and systems for nucleic acid sequencing validation, calibration and normalization |
| 07/20/2011 | EP2344674A2 Methods for treating, diagnosing, and monitoring lupus |
| 07/20/2011 | EP2344672A2 Genetic markers for optimizing treatment for schizophrenia |
| 07/20/2011 | EP2344667A1 Methods for haplotype determination by haplodissection |
| 07/20/2011 | EP2344660A2 Methods and compositions for inactivating glutamine synthetase gene expression |
| 07/20/2011 | EP2344648A2 Recombinant vectors |
| 07/20/2011 | EP2344647A1 Hepatitis c virus expressing reporter tagged ns5a protein |
| 07/20/2011 | EP2344646A2 Clean genome bactofection |
| 07/20/2011 | EP2344645A1 Rodent cancer model for human fgfr4 arg388 polymorphism |
| 07/20/2011 | EP2344644A1 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance biotic stress |
| 07/20/2011 | EP2344643A2 Plant pathogen resistance |
| 07/20/2011 | EP2344642A1 Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus |
| 07/20/2011 | EP2344641A2 Gene transfer vectors comprising at least one isolated dna molecule having insulator and or boundary properties and methods to identify the same |
| 07/20/2011 | EP2344640A1 Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants |
| 07/20/2011 | EP2344639A2 Compositions and methods for inhibiting expression of transthyretin |
| 07/20/2011 | EP2344638A1 Compositions and methods for inhibiting expression of an rna from west nile virus |
| 07/20/2011 | EP2344637A1 Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna |
| 07/20/2011 | EP2344636A2 Novel chimeric ligand-gated ion channels and methods of use thereof |
| 07/20/2011 | EP2344531A1 Modified variant bowman birk protease inhibitors |
| 07/20/2011 | EP2344528A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 07/20/2011 | EP2344524A2 Kit for the optimisation of protein synthesis/secretion |
| 07/20/2011 | EP2344519A2 C-terminal fragments of glucagon-like peptide-1 (glp-1) |
| 07/20/2011 | EP2344514A2 Synthetic methods and derivatives of triphosphate oligonucleotides |
| 07/20/2011 | EP2344193A1 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 07/20/2011 | EP2343967A1 NOVEL At1g67330 GENE INVOLVED IN ALTERED NITRATE UPTAKE EFFICIENCY |
| 07/20/2011 | EP2343966A1 Induced heterosis related mutations |
| 07/20/2011 | EP2147107B1 Expression cloning method suitable for selecting library clones producing a polypeptide of interest |
| 07/20/2011 | EP1994156B1 Chimeric tymovirus-like particles |
| 07/20/2011 | EP1974011B1 Chemical induction of quiescence in bacteria |
| 07/20/2011 | EP1794294B1 Recombinant carboxypeptidase b |
| 07/20/2011 | EP1735465B1 Compositions for use in identification of viral hemorrhagic fever viruses |
| 07/20/2011 | EP1583835B1 Dna array for high throughput solid-phase transfection and method for producing the same |
| 07/20/2011 | EP1373477B1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 07/20/2011 | EP1352074B1 Method for producing homogeneous nucleic acid multimers for use in pharmaceutical compositions |
| 07/20/2011 | EP1230340B1 Methods for the electronic, homogeneous assembly and fabrication of devices |
| 07/20/2011 | EP1214097B3 Nucleic acids encoding polyepitope polypeptides |
| 07/20/2011 | EP1181317B1 An integrin heterodimer and an alpha subunit thereof |